What is Aurora Drug Discovery?
Aurora applies concepts from quantum mechanics and thermodynamics alongside an advanced continuous water model to evaluate solvation effects when determining the binding affinities of ligands. This approach is notably different from the conventional scoring functions that are commonly used to predict binding affinities. By incorporating both entropy and aqueous electrostatic elements into their calculations, the algorithms developed by Aurora provide notably more accurate and dependable estimates of binding free energies. The binding free energy, a key thermodynamic measure, fundamentally dictates the interaction between a ligand and a protein and is directly associated with the experimentally measurable inhibition constant (IC50). Various elements, such as electrostatic interactions, quantum phenomena, solvation dynamics, and the statistical behavior of molecules, all play a role in influencing this free energy (F). The non-additive characteristics of F arise primarily from two key components: the synergistic effects of electrostatic and solvation energies, as well as the entropy present in the system. Gaining a comprehensive understanding of these factors enhances the insight into the molecular interactions that are crucial for effective drug design and development.
Integrations
No integrations listed.
Similar Software to Aurora Drug Discovery
DbVisualizer is a universal database management solution that helps organizations of all sizes work efficiently with relational and NoSQL databases. Built for developers, DBAs, analysts, and data engineers, it scales from startups to teams managing complex environments.
The platform combines a SQL editor with autocomplete, visual query builders, and execution tools for database development and querying. An AI Assistant resolves errors and explains code, while built-in Git integration supports version control and collaboration.
Teams can customize layouts, key bindings, and UI themes, mark frequent scripts and objects as favorites, and apply configurable security settings to meet compliance requirements.
DbVisualizer connects to major databases including MySQL, PostgreSQL, SQL Server, Oracle, Snowflake, SQLite, Cassandra, and BigQuery, and runs on Windows, macOS, and Linux. With nearly 7 million downloads and Pro users in 150 countries, it's a proven fit for businesses of any size.
Learn more
Foxit provides a powerful portfolio of cloud-native APIs built to help organizations streamline, secure, and scale document-centric workflows. Leveraging flexible REST-based architecture, Foxit APIs enable developers to integrate document creation, conversion, extraction, signing, and viewing capabilities directly into their applications—driving greater efficiency and reducing operational complexity.
The Foxit PDF Services API supports high-volume PDF processing tasks such as conversion, extraction, optimization, and redaction. The Document Generation API automates the creation of customized PDFs and DOCX files using dynamic templates and real-time data sources. The Foxit eSign API embeds compliant, legally binding eSignature workflows with advanced audit and tracking features. The PDF Embed API enables fully customizable in-app PDF viewing with support for annotations, forms, and secure access controls.
Together, Foxit APIs deliver a secure, scalable foundation for end-to-end document automation and digital workflow transformation.
Learn more
SILCS
Site-Identification by Ligand Competitive Saturation (SILCS) generates three-dimensional representations called FragMaps, which depict the interactions of various chemical functional groups with a designated target molecule. By uncovering the intricacies of molecular dynamics, SILCS provides essential tools that facilitate the refinement of ligand scaffolds, offering both qualitative and quantitative perspectives on binding sites, which ultimately aids in optimizing the drug design workflow. This methodology utilizes a selection of small molecule probes, each possessing a variety of functional groups, along with explicit solvent modeling and the flexibility of the target molecule to effectively map protein targets. Moreover, the technique empowers researchers to visualize beneficial interactions with the target macromolecule, allowing for a more informed design process. Armed with these insights, scientists can strategically engineer enhanced ligands with functional groups positioned for maximum efficacy. The pioneering approach of SILCS marks a noteworthy leap forward in the realm of medicinal chemistry, opening new avenues for drug discovery and development. Through its advanced analytical capabilities, SILCS not only enhances understanding but also drives innovation in therapeutic design.
Learn more
AutoDock
AutoDock is a suite of automated docking tools designed to predict how small molecules, such as potential drugs or substrates, bind with receptors that possess a known three-dimensional structure. Over the years, this toolkit has seen numerous upgrades and improvements that have led to the creation of multiple docking engines. Presently, AutoDock features two main versions: AutoDock 4 and AutoDock Vina. A recent innovation, AutoDock-GPU, has been launched, significantly speeding up the docking processes of AutoDock 4 to rates that are several hundred times faster than the original single-CPU version. At its core, AutoDock 4 consists of two fundamental applications: autodock, which manages the docking of ligands to a grid representation of the target protein, and autogrid, which pre-calculates these grids. In addition to their primary role in docking, the atomic affinity grids produced can be visualized, offering essential insights that may aid organic synthetic chemists in designing more effective binders for their research endeavors. This visual capability not only enhances the understanding of binding interactions but also fosters a more seamless integration between computational models and tangible results in the realm of drug development.
Learn more
Screenshots and Video
Company Facts
Company Name:
Aurora Fine Chemicals
Date Founded:
1990
Company Location:
United States
Company Website:
aurorafinechemicals.com/drug-discovery-software.html
Product Details
Deployment
SaaS
Support
Standard Support
Web-Based Support
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English